Noninvasive Detection and Assessment of Therapy Response in Multiple Myeloma Using Whole-Body MRI
A legfontosabb adatok
- Ki végzi
- University of Texas Southwestern Medical Center
- Hol
- Dallas (Egyesült Államok)A helyszín megnézése
- Azonosító
- Állapot
- Leállítva
- Résztvevők
- 21 fő vett részt
- Kezdés
- 2020. nov. 30.
- Befejezés
- 2024. ápr. 12.
- A vizsgálat típusa
- Beavatkozással járó
- A vizsgált kezelések
- WBMRI
- Positron Emission Tomography/Computed Tomography (PET/CT)
- A regiszteradat frissítve
- 2025. július 24.
- Miért állt le
- Funding expired before enrollment goal could be reached.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 11 feltétel megnézéseKevesebb
Ki vehet részt
- Patients with pathologically confirmed myeloma
- Eastern Cooperative Oncology Group (ECOG) Performance Status 0, 1, or 2
- For cross-sectional study, no additional required treatment schedule. For longitudinal study: Patients scheduled to undergo bone marrow biopsy (BMB) and induction therapy (or have gone through 1-2 cycles of induction therapy), followed by either bone marrow transplantation (BMT) or consolidation therapy
- Women of child-bearing potential must agree to undergo a urine pregnancy screening to prevent imaging of pregnant patients. A female of child-bearing potential is any woman (regardless of sexual orientation, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria: 1) Has not undergone a hysterectomy or bilateral oophorectomy; or 2) Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months)
- Ability to understand and the willingness to sign a written informed consent
Ki nem vehet részt
- Subjects may not be receiving any other investigational agents for the treatment of the cancer under study
- Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that, in the opinion of the investigator, would limit compliance with study requirements
- Known severe allergic reaction to Gadolinium-based contrast agents
- Subjects must not be pregnant or nursing; since pregnancy is a contraindication to administration of gadolinium-based contrast agents. Furthermore, there is a potential for congenital abnormalities and the potential to harm nursing infants, associated with FDG-PET
- Any contraindication to MRI per Radiology Department's routine protocol, e.g. MRI-incompatible objects, including but not limited to medical devices and other foreign bodies
- Patients with uncontrollable claustrophobia, severe lower back pain, and uncontrollable tremors, to the point that it would render them unable to tolerate an MRI study
Helyszínek itt: Egyesült Államok
- UT Southwestern Medical CenterDallas, Egyesült Államok
A vizsgálatról
Mit akar kideríteni a vizsgálat
This study is designed to prospectively determine the sensitivity, specificity, and diagnostic accuracy of whole-body MRI (WBMRI) with Dual-Echo T2-weighted acquisition for Enhanced Conspicuity of Tumors (DETECT) for the detection of multiple myeloma.
A teljes eredeti leírásKevesebb
Subjects will undergo WBMRI and fluorodeoxyglucose (FDG) positron emission tomography (PET) for research purposes either at one time point for cross-sectional study or at four time points for longitudinal study: baseline, prior to bone marrow transplant (BMT), prior to maintenance therapy, and post BMT. The results of these imaging procedures will be compared to standard of care whole body x-ray and bone marrow biopsy results.
A vizsgálat csoportja
- Multiple Myeloma PatientsA vizsgált kezelés
Patients with pathologically confirmed myeloma for cross-sectional study (detection) or scheduled to undergo induction therapy (or have gone 1-2 cycles of induction therapy), followed by either bone marrow transplantation or consolidation therapy for longitudinal study (therapy response assessment).
Kezelés: WBMRI és Positron Emission Tomography/Computed Tomography (PET/CT)
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- A regiszteradat frissítve
- 2025. július 24.